1. Home
  2. ACIU vs SRI Comparison

ACIU vs SRI Comparison

Compare ACIU & SRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AC Immune SA

ACIU

AC Immune SA

N/A

Current Price

$2.12

Market Cap

229.7M

Sector

Health Care

ML Signal

N/A

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

N/A

Current Price

$5.08

Market Cap

205.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
ACIU
SRI
Founded
2003
1965
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
229.7M
205.1M
IPO Year
2015
1997

Fundamental Metrics

Financial Performance
Metric
ACIU
SRI
Price
$2.12
$5.08
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $8.58
N/A
AVG Volume (30 Days)
★ 195.8K
190.5K
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $824,444,000.00
Revenue This Year
$422.39
N/A
Revenue Next Year
$377.85
$2.90
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 18.46
52 Week Low
$2.02
$4.60
52 Week High
$3.90
$9.71

Technical Indicators

Market Signals
Indicator
ACIU
SRI
Relative Strength Index (RSI) 41.11 33.70
Support Level $2.09 $4.65
Resistance Level $2.57 $7.51
Average True Range (ATR) 0.19 0.33
MACD -0.00 -0.03
Stochastic Oscillator 18.69 18.24

Price Performance

Historical Comparison
ACIU
SRI

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Geographically, the company generates key revenue from the United States.

Share on Social Networks: